Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Our writer reveals what he thinks is the most exciting from the four investments he made in his Stocks and Shares ISA last ...

Investing.com -- AI-related stocks topped trading activity on Robinhood U.K. in June, led by Nvidia (NASDAQ: NVDA ), ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...

你是否听说过诺和诺德与Hims&Hers的短暂合作？这场仅维持58天的商业联姻戛然而止，引发了市场的广泛关注。诺和诺德的愤怒声明不仅揭示了减肥药市场的复杂局势，也折射出全球制药行业面临的生存危机。

California lawmakers introduced bills to increase doctors' menopause training. ( NPR) The majority of people in the U.S. who ...

智通财经APP获悉，在诺和诺德(NVO.US)终止与远程医疗公司Hims & Hers Health合作后，摩根士丹利发布研报给予Hims & Hers ...

智通财经APP获悉，在诺和诺德 (NVO.US)终止与远程医疗公司Hims & Hers Health合作后，摩根士丹利发布研报给予 Hims & Hers Health (HIMS.US)“与大盘持平”评级，最新目标价40美元。

Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Hims & Hers Health, Inc ...